Tuesday, 20 December 2016

Akebia sells rights to anemia drug to Japan's Otsuka

(Reuters) - Drug developer Akebia Therapeutics Inc said on Tuesday it had signed a co-development and marketing deal worth up to $1 billion with Japan's Otsuka Holdings Co Ltd.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)